This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ahmad A. Mallouh, MD; A. Rahman Sa'di, MD

Am J Dis Child. 1992;146(8):965-967.

Abstract
• Agnogenic myeloid metaplasia is a chronic myeloproliferative disorder characterized by splenomegaly, leukoerythroblastosis, extramedullary hematopoiesis, teardrop-shaped red blood cells, and fibrosis of the bone marrow. It is a disease of adults, with only one case report in the pediatric literature. The symptoms of the patient in this case clearly fit the diagnostic criteria of this disease. Myelofibrosis in children is usually of the acute type, presenting in infancy and running a fulminant, fatal course with minimal or mild splenomegaly. Red blood cells are usually normal on morphologic examination.Three infants, including two siblings, presented at ages 9, 10, and 16 months with clinical and laboratory findings consistent with agnogenic myeloid metaplasia. The occurrence of the disease in these siblings is suggestive of an autosomal recessive mode of inheritance.

(AJDC. 1992;146:965-967)

Author Affiliations
From the Pediatric Services (Dr Mallouh) and Pathology Services (Dr Sa'di) Divisions, the Saudi Aramco—Dhahran (Saudi Arabia) Health Center.

Footnotes
Accepted for publication February 11, 1992.

Reprint requests to the Saudi Aramco—Dhahran Health Center, Box 76, Dhahran 31311, Saudi Arabia (Dr Mallouh).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Myelofibrosis With Myeloid Metaplasia: Diagnostic Definition and Prognostic Classification for Clinical Studies and Treatment Guidelines
Barosi
JCO 1999;17:2954-2954.
ABSTRACT | FULL TEXT